ROCKET PHARMACEUTICALS, INC. (RCKT) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rocket Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Rocket Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $4.77 M, a 2284% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $4.77 M +$4.57 M +2284% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.9 M +$1.93 M +97.8% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $4.09 M +$3.07 M +300% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $4.35 M +$3.14 M +260% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $200 K -$1.19 M -85.6% Mar 31, 2023 10-K 2024-02-27
Q4 2022 $1.97 M +$403 K +25.7% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.02 M -$445 K -30.3% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.21 M -$421 K -25.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.39 M -$397 K -22.2% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.57 M +$655 K +71.7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.47 M +$373 K +34.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $1.63 M +$358 K +28.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.79 M +$317 K +21.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $914 K -$1.14 M -55.4% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $1.09 M -$1.16 M -51.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $1.27 M -$1.18 M -48.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $1.47 M -$1.18 M -44.5% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.05 M +$2.05 M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.25 M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $2.45 M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.65 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.